# Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer

> **NCT03636776** · NA · TERMINATED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 60 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Positive Hormonal Receptors

## Interventions

- **OTHER:** Quality of life in metastatic BC

## Key facts

- **NCT ID:** NCT03636776
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-29
- **Primary completion:** 2022-01-11
- **Final completion:** 2022-01-11
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** The sponsor has set up a secondary competitive study concerning the same population and whose secondary objectives are the same as those of the EPOCA study with the same endpoints.
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03636776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03636776, "Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03636776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*